Nexiclon Xr Tablet, Extended Release
Product Images NDC 71511-503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nexiclon Xr (NDC 71511-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rosemont Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nexiclon-30.jpg (Image)

Nexiclon-30.jpg (Image)
Nexiclon XR 0.17 mg extended-release tablets label showing the proprietary product name and generic name (clonidine). The label indicates 30 tablets in the package, with dosage strength marked as 0.17 mg. It is manufactured by Athena Bioscience, LLC, Athens, GA. Additional storage instructions and formulation details are also visible.*
FDA Label Image

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)
Chemical structure of clonidine, the active ingredient in Nexiclon XR (extended-release oral tablet). The diagram shows the molecular structure including a dichlorophenyl ring linked to an imidazoline ring and paired with hydrochloride (HCl).*
FDA Label Image

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)
Line graph depicting mean concentration (pg/mL) of three different samples (labeled A, B, and C) over a 72-hour period. The x-axis shows time in hours, and the y-axis shows mean concentration. Concentrations rise to peaks between 6 and 12 hours, then decline steadily toward 72 hours.*
FDA Label Image

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)
A line graph depicting systolic and diastolic blood pressure measurements over a 24-hour period for two dosage forms of clonidine: 0.6 mg extended release (ER) and 0.3 mg twice daily immediate release (BID IR). The x-axis represents time points from 0 to 24 hours while seated, and the y-axis shows blood pressure in mmHg. Four lines track systolic and diastolic pressures for each dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.